(Generic Name (Generic Name and (Generic Name and (Generic Name and (Generic Name and Brand

eneric Name and Brand (Generic Name and Brand (Generic Name and
and Brand Brand Name) Brand Name) Brand Name) Name) Dosage, Route and Name) Dosage, Route and Brand Name) Dosage,
Name) Dosage, Dosage, Route and Dosage, Route and Dosage, Route and Frequency (Actual Frequency (Actual prescribe by Route and Frequency
Route and Frequency (Actual Frequency (Actual Frequency (Actual prescribe by the doctor) the doctor) Mechanism of (Actual prescribe by
Frequency prescribe by the prescribe by the prescribe by the Mechanism of Action Action Indication Adverse the doctor) Mechanism
(Actual doctor) Mechanism doctor) Mechanism doctor) Mechanism Indication Adverse Effect Effect Contraindication s Health of Action Indication
prescribe by the of Action Indication of Action Indication of Action Contraindication s Health Care provider Adverse Effect
doctor) Adverse Effect Adverse Effect Indication Adverse Care provider Contraindication s
Mechanism of Contraindication s Contraindication s Effect Health Care provider
Action Health Care provider Health Care provider Contraindication s
Indication Health Care
Adverse Effect provider
Contraindicatio
n s Health Care
provider
Generic Name: Pharmacologic: Decreases Management of > Hypersensitivity CNS: Dizziness/headache > check the doctor’s
Losartan contractions in outflow order
Potassium
Peripherally acting smooth muscle of obstruction in Precautions: EENT: rhinitis > Observe the 15
Brand Name: anti-adrenergics the prostatic male patients with Use cautiously with rights of drug
Cozaar capsule by prostatic patients at risk for CV: orthostatic hypotension administration
preferentially hyperplasia. prostate > administer daily
binding to alpha- carcinoma(symptoms GU: retrograde/diminished dose orally 30 min
Classifications:
Cardiovascular
adrenergic maybe similar) ejaculation after the same meal
agent; angiotensin receptors. each day
II receptor Decreased >monitor intake and
antagonist; symptoms os Interactions: output ratios daily
antihypertensive prostichyperplasia. > drug-drug: and assess for
Therapeutic: CIMITIDINE may edema daily. Report
None increase blood levels weight gain or
and the risk for toxicity. edema.
Increased risk of >if dose is
Pregancy Category hypotension with other interrupted, restart
B peripherally acting anti- the medication
adrinergics, concurrent >caution patient and
use should be avoided. significant others to
change positions
slowly to minimize
orthostatic
hypotension.
 MECHANISM OF NURSING
DRUG DATA CLASSIFICATION INDICATIONS CONTRAINDICATION ADVERSE EFFECTS
ACTION RESPONSIBILITIES
Generic Pharmacologic: Inhibits the Can be used with > Hypersensitivity in GU: decreased libido, > check the doctor’s
Name: enzyme 5-alpha doxazosin. women decrease volume of order
Androgen reductase which is Androgenetic ejaculate , erectile > Observe the 15
finasteride inhibitors responsible for alopecia in men Precautions: dysfunction. rights of drug
converting only. Use cautiously inpatients administration
testosterone to its with hepatic impairment > administer daily
potent metabolite. or obstructive dose orally with or
Trade neuropathy without meal.
name/s:prope
cia/proscar
Interactions:
Patient’s > drug-drug: none noted.
dose: Therapeutic:
5 mg PO Hair regrowth
stimulants
Maximum
Dose:
5 mg PO Pregancy Category
X
Minimum
Dose:
5 mg PO

Availability:
Tablet 1 mg/ 5
mg

Route:
Oral
Drug Classificati Action Indication Consideration Side Effect Nursing
Name on Consideration
Genenric  3rd  Works by  Indicated in  Hypersensitiv  Pain  Assess patient’s
name: generatio inhibiting the patients with e to  Induration previous
Ceftriazon n mucopeptide neurologic cephalosporin  Phlebitis sensitivityreaction
e cephalosp synthesis in the complications, s, penicillins  Rash to penicillin or
orin. bacterial cell carditis and and related  Diarrhea other
Brand wall. The beta- arthritis. It is also antibiotics.  Thrombocyt cephalosphorins.
Name: lactam moiety effective in Gram osis  Assess patient for
Forgram of Ceftriaxone negative signs and
 Leucopenia
binds to infections; symptoms of
 Glossitis
Dosage: carboxypeptida Meningitis, infection before
450mg  Respiratory
ses, Gonorrhea. It is andduring the
TIV q12 super
endopeptidases also for Bone and treatment
infections
, and joint infections,  Obtain C&S
transpeptidases Lower respiratory before beginning
in the bacterial tract infections, drug therapy
cytoplasmicme middle ear toidentify if
mbrane. These infection, PID, correcttreatment
enzymes are Septicemia and has beeninitiated.
involved in Urinary Tract  Report signs such
cell-wall infections. as petechiae,
synthesis and ecchymotic areas,
cell division. epistaxis or other
By binding to forms of
these enzymes, unexplained
Ceftriaxone bleeding.
results in the  Monitor
formation of of hematologic,
defective cell electrolytes, renal
walls and cell and hepatic
death. function.
 Assess for
possibles upper
infection: itching
fever, malaise,
redness